Similar articles

• Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply.

  Croft A, Walsh A, Doecke J, Radford-Smith G. Croft A, et al. Aliment Pharmacol Ther. 2013 Oct;38(8):993. doi: 10.1111/apt.12474. Aliment Pharmacol Ther. 2013. PMID: 24074312 No abstract available.
• Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab?

  Sprakes MB, Hamlin PJ. Sprakes MB, et al. Aliment Pharmacol Ther. 2013 Oct;38(8):988. doi: 10.1111/apt.12436. Aliment Pharmacol Ther. 2013. PMID: 24074307 No abstract available.
• Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab? Author's reply.

  Croft A, Walsh A, Doecke J, Radford-Smith G. Croft A, et al. Aliment Pharmacol Ther. 2013 Oct;38(8):989. doi: 10.1111/apt.12475. Aliment Pharmacol Ther. 2013. PMID: 24074308 No abstract available.
• Review article: the optimal medical management of acute severe ulcerative colitis.

  Hart AL, Ng SC. Hart AL, et al. Aliment Pharmacol Ther. 2010 Sep;32(5):615-27. doi: 10.1111/j.1365-2036.2010.04392.x. Aliment Pharmacol Ther. 2010. PMID: 20626381 Review.
• Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.

  Farkas K, Molnár T, Szepes Z. Farkas K, et al. Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):695-702. doi: 10.1586/17474124.2014.909726. Epub 2014 Apr 17. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24738535 Review.